Literature DB >> 11574086

Outcome of extra-anatomic vascular reconstruction in orthotopic liver transplantation.

C R Cappadonna1, L B Johnson, A D Lu, P C Kuo.   

Abstract

BACKGROUND: Portal venous and hepatic arterial reconstruction are critical to successful outcomes in orthotopic liver transplantation (OLT). With portal vein thrombosis or inadequate hepatic arterial inflow, extra-anatomic vascular reconstruction is required. However, the clinical outcomes following extra-anatomic vascular reconstruction are largely unknown.
METHODS: To determine the outcomes associated with extra-anatomic vascular reconstruction, we performed a retrospective review of 205 OLT recipients transplanted between 1995 and 2000.
RESULTS: Extra-anatomic portal venous inflow was based upon the recipient superior mesenteric vein using donor iliac vein graft in a retrogastric position (n = 12). Extra-anatomic arterial inflow was based on recipient infrarenal aorta using donor iliac artery graft through the transverse mesocolon (n = 25). OLT with routine anatomic vascular construction served as control (n = 168). Extra-anatomic vascular reconstruction was not associated with increased morbidity, mortality, operating room time, length of stay, or thrombosis.
CONCLUSION: We conclude that extra-anatomic vascular conduits are associated with excellent long-term outcomes and provide acceptable alternatives for vascular reconstruction in OLT.

Entities:  

Mesh:

Year:  2001        PMID: 11574086     DOI: 10.1016/s0002-9610(01)00675-4

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  2 in total

1.  Vascular complications following liver transplantation.

Authors:  James C Andrews
Journal:  Semin Intervent Radiol       Date:  2004-12       Impact factor: 1.513

2.  Liberal Use of Interposition Grafts for Arterial Reconstruction Is Safe and Effective in Adult Split Liver Transplantation.

Authors:  Ngee-Soon Lau; Ken Liu; Abdullah Almoflihi; Josephine Xu; Geoffrey McCaughan; Michael Crawford; Carlo Pulitano
Journal:  Transplant Direct       Date:  2021-07-23
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.